Lobe SciencesLOBEF -7.24% Market Cap is $18.00 Mil as of Jun. 28, 2026. The stock has 2 warning signs investors should review. Among 1,429 Biotechnology companies, Lobe Sciences ranks worse than 77.4% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Lobe Sciences's share price for the quarter that ended in Feb. 2026 was $0.04536. Lobe Sciences's Shares Outstanding (EOP) for the quarter that ended in Feb. 2026 was 269.49 Mil. Therefore, Lobe Sciences's market cap for the quarter that ended in Feb. 2026 was $12.22 Mil.
Lobe Sciences's quarterly market cap
declined
from Aug. 2025 ($9.77 Mil) to Nov. 2025 ($9.43 Mil) but then
increased
from Nov. 2025 ($9.43 Mil) to Feb. 2026 ($12.22 Mil).
Lobe Sciences's annual market cap
increased
from Aug. 2023 ($1.34 Mil) to Aug. 2024 ($2.71 Mil) and
increased
from Aug. 2024 ($2.71 Mil) to Aug. 2025 ($9.77 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Lobe Sciences's Enterprise Value for Today is $15.83 Mil.
Lobe Sciences (OTCPK:LOBEF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Lobe Sciences Market Cap Related Terms
Lobe Sciences Market Cap Historical Data
* Premium members only.
The historical data trend for Lobe Sciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Lobe Sciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lobe Sciences Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Lobe Sciences's Market Cap distribution charts can be found below:
* The bar in red indicates where Lobe Sciences's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Lobe Sciences's Market Cap for the fiscal year that ended in Aug. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lobe Sciences (LOBEF) has a Market Cap of $18.00 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Lobe Sciences and its competitors. According to the industry distribution chart, Lobe Sciences ranks #1106 out of 1429 companies in the Biotechnology industry, placing it in the top 77.4%.
Is Lobe Sciences' Market Cap too high?
Lobe Sciences' current Market Cap is $18.00 Mil. The Biotechnology industry median Market Cap is 112.70. Lobe Sciences' value of $18.00 Mil is 84% below this industry median. Based on the distribution chart, Lobe Sciences ranks #1106 out of 1429 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Lobe Sciences' Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Lobe Sciences ranks #1106 out of 1429 companies for Market Cap. This places Lobe Sciences in the lower half of its industry. The industry median Market Cap is 112.70. Lobe Sciences' value of $18.00 Mil is 84% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 112.70, based on 1,429 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lobe Sciences's current Market Cap of $18.00 Mil is 84% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Lobe Sciences and its competitors. For the Biotechnology industry, the median Market Cap is 112.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lobe Sciences's current Market Cap is $18.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lobe Sciences stock overvalued right now?
Lobe Sciences (LOBEF) has a current Market Cap of $18.00 Mil. The current Market Cap is $18.00 Mil and 84% below the Biotechnology industry median of 112.70. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Lobe Sciences (LOBEF), the current Market Cap is $18.00 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lobe Sciences Ltd is a biopharmaceutical company focused on using lipid technology that develop therapies for orphan and rare diseases. It commercializes Altemia MF, a medical food intended to address nutritional deficiencies associated with sickle cell disease. Through its subsidiaries, the company also holds a majority interest in the development of Conjugated Psilocin for potential use in neurological and psychiatric indications. The company operates in one reportable segment, being the biopharmaceutical development of new medicines.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LOBEF has been successfully added to your 